Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection

References

• Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci. 1992;13(1):24–8. doi: 10.1016/0165-6147(92)90012-U
   PubMed Web of Science ®Google Scholar
• Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002;25(3):154–9. doi: 10.1016/S0166-2236(00)02088-9
   PubMed Web of Science ®Google Scholar
• Pariante CM. Chronic fatigue syndrome and the immune system: “findings in search of meanings”. Brain Behav Immun. 2009;23(3):325–6. doi: 10.1016/j.bbi.2009.01.006
   PubMed Web of Science ®Google Scholar
• Dantzer R. Somatization: a psychoneuroimmune perspective. Psychoneuroendocrinology. 2005;30(10):947–52. doi: 10.1016/j.psyneuen.2005.03.011
   PubMed Web of Science ®Google Scholar
• Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12(2):123–37. doi: 10.1016/S0149-7634(88)80004-6
   PubMed Web of Science ®Google Scholar
• Su KP. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a ‘mind-body interface’? Neurosignals 2009;17(2):144–52. doi: 10.1159/000198167
   PubMedGoogle Scholar
• Su KP, Huang SY, Peng CY, Lai CH, Huang CL, Chen YC, et al. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry. 2010;67(6):550–7. doi: 10.1016/j.biopsych.2009.11.005
   PubMed Web of Science ®Google Scholar
• Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP, et al. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry. 2014;76(7):559–66. doi: 10.1016/j.biopsych.2014.01.008
   PubMed Web of Science ®Google Scholar
• Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006;1(4):420–39. doi: 10.1002/biot.200600012
   PubMedGoogle Scholar
• Su KP. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression. Asia Pac J Clin Nutr. 2008;17(Suppl. 1):151–7.
   PubMed Web of Science ®Google Scholar
• Pae Cu, Yu HS, Kim JJ, Lee CU, Lee SJ, Jun TY, et al. BanI polymorphism of the cytosolic phospholipase A2 gene and mood disorders in the Korean population. Neuropsychobiology. 2004;49(4):185–8. doi: 10.1159/000077364
   PubMed Web of Science ®Google Scholar
• Riemer S, Maes M, Christophe A, Rief W. Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J Affect Disord. 2010;123(1–3):173–80. doi: 10.1016/j.jad.2009.08.004
   PubMed Web of Science ®Google Scholar
• Valentine AD, Meyers CA, Talpaz M. Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Invest. 1995;13(6):561–6. doi: 10.3109/07357909509024923
   PubMed Web of Science ®Google Scholar
• Tylee A. Low recognition of depression among outpatients by internists in China. Evid Based Ment Health. 2009;12(2):64. doi: 10.1136/ebmh.12.2.64
   PubMedGoogle Scholar
• Lu DY, Leung YM, Su KP. Interferon-alpha induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellular mechanism of IFN-alpha-induced depression. Int J Neuropsychopharmacol. 2013;16(2):433–44. doi: 10.1017/S1461145712000338
   PubMed Web of Science ®Google Scholar
• Talarowska M, Szemraj J, Galecki P. Myeloperoxidase gene expression and cognitive functions in depression. Adv Med Sci. 2015;60(1):1–5. doi: 10.1016/j.advms.2014.06.001
   PubMed Web of Science ®Google Scholar
• Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010;68(2):140–7. doi: 10.1016/j.biopsych.2010.03.018
   PubMed Web of Science ®Google Scholar
• Lin PY, Mischoulon D, Freeman MP, Matsuoka Y, Hibbeln J, Belmaker RH, et al. Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry. 2012;17(12):1161–3 [author reply 1163–1167]. doi: 10.1038/mp.2012.111
   PubMed Web of Science ®Google Scholar
• Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056–61. doi: 10.4088/JCP.v68n0712
   PubMed Web of Science ®Google Scholar
• Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr. 2009;28(5):525–42. doi: 10.1080/07315724.2009.10719785
   PubMed Web of Science ®Google Scholar
• Martins JG, Bentsen H, Puri BK. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry. 2012;17(12):1144–9 [discussion 1163–1147]. doi: 10.1038/mp.2012.25
   PubMed Web of Science ®Google Scholar
• Bufalino C, Hepgul N, Aguglia E, Pariante CM. The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav Immun. 2013;31:31–47. doi: 10.1016/j.bbi.2012.04.009
   PubMed Web of Science ®Google Scholar
• Su K-P. Inflammation in psychopathology of depression: clinical, biological, and therapeutic implications. BioMedicine. 2012;2(2):68–74. doi: 10.1016/j.biomed.2012.03.002
   Google Scholar
• Su KP, Wang SM, Pae CU. Omega-3 polyunsaturated fatty acids for major depressive disorder. Expert Opin Investig Drugs. 2013;22(12):1519–34. doi: 10.1517/13543784.2013.836487
   PubMed Web of Science ®Google Scholar
• Chang JP, Chang SS, Yang HT, Palani M, Chen CP, Su KP. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression. Brain Behav Immun. 2015;44:28–31. doi: 10.1016/j.bbi.2014.11.005
   PubMed Web of Science ®Google Scholar
• Chang JP, Chen YT, Su KP. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) in cardiovascular diseases (CVDs) and depression: the missing link? Cardiovasc Psychiatry Neurol. 2009;2009:1. doi: 10.1155/2009/725310
   Google Scholar
• Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry. 2000;47(1):8–21. doi: 10.1016/S0006-3223(99)00092-X
   PubMed Web of Science ®Google Scholar
• Maes M, Smith RS. Fatty acids, cytokines, and major depression. Biol Psychiatry. 1998;43(5):313–14. doi: 10.1016/S0006-3223(97)00401-0
   PubMed Web of Science ®Google Scholar
• Song C, Leonard BE, Horrobin DF. Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress Int J Biol Stress. 2004;7(1):43–54. doi: 10.1080/10253890410001667188
   PubMed Web of Science ®Google Scholar
• Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001;24(8):450–55. doi: 10.1016/S0166-2236(00)01854-3
   PubMed Web of Science ®Google Scholar
• Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36(9):1007–24. doi: 10.1007/s11745-001-0812-7
   PubMed Web of Science ®Google Scholar
• Song C. Omega-3, but not antidepressant sertraline, attenuates IL-1-induced release of neurotransmitters in the nucleus accumbens: an in vivo microdialysis study. Brain Behav Immun. 2002;16(A):557. doi: 10.1016/S0889-1591(02)00012-0
   PubMed Web of Science ®Google Scholar
• Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765–68. doi: 10.1126/science.288.5472.1765
   PubMed Web of Science ®Google Scholar
• Shapiro H. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins Leukot Essent Fatty Acids. 2003;68(3):219–24. doi: 10.1016/S0952-3278(02)00273-9
   PubMed Web of Science ®Google Scholar